GE sells biopharma unit for $21 billion

GE sells biopharma unit for $21 billion

General Electric said Monday it would sell its biopharma business to Danaher Corp for $21 billion, its first major asset sale under new CEO Larry Culp. The deal is expected to provide GE with a much needed cash infusion as the company struggles to pay off billions of dollars of debt and insurance liabilities.

KCooper
KCooper
Top in Business
Get the App